ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

Development of 2,5-dihydro-4H-pyrazolo[3,4-d]pyrimidin-4-one inhibitors of aldehyde dehydrogenase 1A (ALDH1A) as potential adjuncts to ovarian cancer chemotherapy

Huddle, Brandt C.; Grimley, Edward; Chtcherbinine, Mikhail; Buchman, Cameron D.; Takahashi, Cyrus; Debnath, Bikash; McGonigal, Stacy C.; Mao, Shuai; Li, Siwei; Felton, Jeremy; Pan, Shu; Wen, Bo; Sun, Duxin; Neamati, Nouri; Buckanovich, Ronald J.; Hurley, Thomas D.; Larsen, Scott D.*
European Journal of Medicinal Chemistry2021-2-5DOI: 10.1016/j.ejmech.2020.113060
10被引3阅读
引用收藏
分享

摘要

There is strong evidence that inhibition of one or more Aldehyde Dehydrogenase 1A (ALDH1A) isoforms may be beneficial in chemotherapy-resistant ovarian cancer and other tumor types. While many previous efforts have focused on development of ALDH1A1 selective inhibitors, the most deadly ovarian cancer subtype, high-grade serous (HGSOC), exhibits elevated expression of ALDH1A3. Herein, we report continued development of pan-ALDH1A inhibitors to assess whether broad spectrum ALDH1A inhibition is an effective adjunct to chemotherapy in this critical tumor subtype. Optimization of the CM39 scaffold, aided by metabolite ID and several new ALDH1A1 crystal structures, led to improved biochemical potencies, improved cellular ALDH inhibition in HGSOC cell lines, and substantial improvements in microsomal stability culminating in orally bioavailable compounds. We demonstrate that two compounds 68 and 69 are able to synergize with chemotherapy in a resistant cell line and patient-derived HGSOC tumor spheroids, indicating their suitability for future in vivo proof of concept experiments.

学科与关键词

关键词
Aldehyde dehydrogenase inhibitorALDH inhibitorChemoresistantOvarian cancer
相关
加载中…
  • Blockade of ALDH in Cisplatin-Resistant Ovarian Cancer Stem Cells In Vitro Synergistically Enhances Chemotherapy-Induced Cell Death
    Guo, Fang; Yang, Zhi; Sehouli, Jalid; Kaufmann, Andreas M.*Current Oncology, 2022, 29(4): 2808-2822.被引 9
  • ALDH1A1 promotes PARP inhibitor resistance by enhancing retinoic acid receptor-mediated DNA polymerase θ expression
    Lavudi Kousalya; Banerjee Ananya; Li Na; Yang Yajing; Cai Shurui; Bai Xuetao; Zhang Xiaoli; Li Aidan; Wani Elsa; Yang Shyh-Ming; Zhang Junran; Rai Ganesha; Backes Floor; Patnaik Srinivas; Guo Peixuan; Wang Qi-Ennpj Precision Oncology, 2023, 7(1): 66.
  • Metformin and phenethyl isothiocyanate combined treatment in vitro is cytotoxic to ovarian cancer cultures
    Daniel K Chan; W MiskiminsJournal of Ovarian Research, 2012, 5(1): 19.
查看全部 →

发表信息

论文状态
公开发表
期刊
European Journal of Medicinal Chemistry
发表日期
2021-02-05
卷期
第 211 卷
页码
113060
DOI
10.1016/j.ejmech.2020.113060
语言
MULTI-LANGUAGE
期刊收录
NSL
期刊等级
1区
成果收录
SCIE
资助标注
National Cancer Institute of the National Institutes of Health [R01 CA214567-01]; U.S. Department of Energy, Office of Biological and Environmental Research [DE-AC02-06CH11357]

作者

  • H

    Huddle, Brandt C. (第一作者)

  • G

    Grimley, Edward

查看全部 17 位作者收起作者
  • C

    Chtcherbinine, Mikhail

  • B

    Buchman, Cameron D.

  • T

    Takahashi, Cyrus

  • D

    Debnath, Bikash

  • M

    McGonigal, Stacy C.

  • M

    Mao, Shuai

  • L

    Li, Siwei

  • F

    Felton, Jeremy

  • P

    Pan, Shu

  • W

    Wen, Bo

  • S

    Sun, Duxin

  • N

    Neamati, Nouri

  • B

    Buckanovich, Ronald J.

  • H

    Hurley, Thomas D.

  • L

    Larsen, Scott D. (通讯)

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417